Humanized antibody molecules specific for IL-31
US8470979B2 · kind B2 · utility
31Cited by
47References
40Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 8, 2008 |
| Grant date | Jun 25, 2013 |
| Priority date | — |
| Expiry date | Jul 11, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized mouse anti-human IL-31 antibodies and antibody fragments that are capable of binding IL-31 and thereby neutralizing, inhibiting, limiting, or reducing the proinflammatory or pro-pruritic effects of IL-31.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.